Select a relevant service

Evaluate data collected during drug development to maximize the value of a therapeutic product.

Find general strategies and methods used to market a pharmaceutical product or device.

Use mathematical variables and equations to establish relationships between data.

Run market feasibility studies, establish customer needs, improve product performance and analyze competition.

Compare alternative treatments that lead to similar health outcomes.

Develop value story tailored to a payer audience that will determine the appropriate price for treatment.

Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.

Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder (manufacturer, payer, provider, HTA agency, etc.). See also HTA Submission.

The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.

Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern submissions. See also AMCP and Value Dossier.